$BMTI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMIMETIC THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIOMIMETIC THERAPEUTICS, INC.. Get notifications about new insider transactions in BIOMIMETIC THERAPEUTICS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 06 2013 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Sell | D | 0.00 | 4,720,065 | 0 | 0 | 4.7 M to 0 (-100.00 %) |
Mar 06 2013 | BMTI | BIOMIMETIC THERAPE ... | Christensen Thorkil K. | Director | Sell | D | 0.00 | 2,507 | 0 | 0 | 2.5 K to 0 (-100.00 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Ehrlich Christopher B | Director | Option Exercise | D | 11.64 | 8,840 | 102,898 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Ehrlich Christopher B | Director | Option Exercise | D | 17.09 | 5,831 | 99,652 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Ehrlich Christopher B | Director | Sell | D | 0.00 | 24,538 | 0 | 0 | 24.5 K to 0 (-100.00 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Ehrlich Christopher B | Director | Sell | D | 0.00 | 6,846 | 0 | 0 | 6.8 K to 0 (-100.00 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Ehrlich Christopher B | Director | Sell | D | 0.00 | 857,692 | 0 | 0 | 857.7 K to 0 (-100.00 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Ehrlich Christopher B | Director | Sell | D | 0.00 | 941,177 | 0 | 0 | 941.2 K to 0 (-100.00 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Ehrlich Christopher B | Director | Sell | D | 0.00 | 1,250 | 0 | 0 | 1.3 K to 0 (-100.00 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Option Exercise | D | 12.66 | 8,538 | 108,091 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Option Exercise | D | 9.95 | 10,653 | 105,997 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Option Exercise | D | 11.64 | 8,840 | 102,898 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Option Exercise | D | 17.09 | 5,831 | 99,652 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Option Exercise | M | 2.63 | 20,000 | 52,600 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Option Exercise | M | 5.80 | 18,736 | 108,669 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Sell | D | 0.00 | 4,258 | 0 | 0 | 4.3 K to 0 (-100.00 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Sell | D | 0.00 | 3,377 | 0 | 0 | 3.4 K to 0 (-100.00 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Sell | D | 0.00 | 4,258 | 0 | 0 | 4.3 K to 0 (-100.00 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Sell | D | 0.00 | 11,762 | 0 | 0 | 11.8 K to 0 (-100.00 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Sell | D | 0.00 | 14,894 | 0 | 0 | 14.9 K to 0 (-100.00 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Sell | D | 0.00 | 64,957 | 0 | 0 | 65 K to 0 (-100.00 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Payment of Exercise | F | 9.07 | 5,797 | 52,579 | 64,957 | 70.8 K to 65 K (-8.19 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Buy | M | 2.63 | 20,000 | 52,600 | 70,754 | 50.8 K to 70.8 K (+39.41 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Payment of Exercise | F | 9.07 | 11,977 | 108,631 | 50,754 | 62.7 K to 50.8 K (-19.09 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Buy | M | 5.80 | 18,736 | 108,669 | 62,731 | 44 K to 62.7 K (+42.59 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | FEDERICO CHARLES | Director | Option Exercise | D | 12.66 | 8,538 | 108,091 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | FEDERICO CHARLES | Director | Option Exercise | D | 9.95 | 10,653 | 105,997 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | FEDERICO CHARLES | Director | Option Exercise | D | 11.64 | 8,840 | 102,898 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | FEDERICO CHARLES | Director | Option Exercise | D | 17.09 | 18,096 | 309,261 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | FEDERICO CHARLES | Director | Option Exercise | M | 2.63 | 20,000 | 52,600 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | FEDERICO CHARLES | Director | Option Exercise | M | 5.80 | 18,736 | 108,669 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | FEDERICO CHARLES | Director | Sell | D | 0.00 | 27,834 | 0 | 0 | 27.8 K to 0 (-100.00 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | FEDERICO CHARLES | Director | Buy | M | 2.63 | 20,000 | 52,600 | 27,834 | 7.8 K to 27.8 K (+255.30 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | FEDERICO CHARLES | Director | Payment of Exercise | F | 9.07 | 11,977 | 108,677 | 7,834 | 19.8 K to 7.8 K (-60.46 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | FEDERICO CHARLES | Director | Buy | M | 5.80 | 18,736 | 108,669 | 19,811 | 1.1 K to 19.8 K (+1,742.88 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | MURPHY JAMES G | Director | Option Exercise | D | 12.66 | 8,538 | 108,091 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | MURPHY JAMES G | Director | Option Exercise | D | 9.95 | 10,653 | 105,997 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | MURPHY JAMES G | Director | Option Exercise | D | 11.64 | 8,840 | 102,898 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | MURPHY JAMES G | Director | Option Exercise | D | 17.09 | 5,831 | 99,652 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | MURPHY JAMES G | Director | Option Exercise | M | 2.63 | 20,000 | 52,600 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | MURPHY JAMES G | Director | Option Exercise | M | 5.80 | 18,736 | 108,669 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | MURPHY JAMES G | Director | Sell | D | 0.00 | 56,964 | 0 | 0 | 57 K to 0 (-100.00 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | MURPHY JAMES G | Director | Buy | M | 2.63 | 20,000 | 52,600 | 56,964 | 37 K to 57 K (+54.11 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | MURPHY JAMES G | Director | Buy | M | 5.80 | 18,736 | 108,669 | 36,964 | 18.2 K to 37 K (+102.79 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Pagano Russell P. | VP, Reg. & Clinical ... | Option Exercise | D | 9.70 | 25,000 | 242,500 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Pagano Russell P. | VP, Reg. & Clinical ... | Option Exercise | D | 11.97 | 35,000 | 418,950 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Pagano Russell P. | VP, Reg. & Clinical ... | Option Exercise | D | 8.54 | 35,000 | 298,900 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Pagano Russell P. | VP, Reg. & Clinical ... | Option Exercise | D | 13.45 | 35,000 | 470,750 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Pagano Russell P. | VP, Reg. & Clinical ... | Option Exercise | D | 14.41 | 10,000 | 144,100 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Pagano Russell P. | VP, Reg. & Clinical ... | Option Exercise | M | 2.08 | 70,000 | 145,600 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Pagano Russell P. | VP, Reg. & Clinical ... | Sell | D | 0.00 | 44,411 | 0 | 0 | 44.4 K to 0 (-100.00 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Pagano Russell P. | VP, Reg. & Clinical ... | Payment of Exercise | F | 9.07 | 32,305 | 293,129 | 44,411 | 76.7 K to 44.4 K (-42.11 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Pagano Russell P. | VP, Reg. & Clinical ... | Buy | M | 2.08 | 70,000 | 145,600 | 76,716 | 6.7 K to 76.7 K (+1,042.29 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | D | 12.66 | 8,538 | 108,091 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | D | 9.95 | 10,653 | 105,997 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | D | 11.64 | 8,840 | 102,898 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | D | 17.09 | 5,831 | 99,652 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 2.63 | 20,000 | 52,600 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 5.80 | 18,736 | 108,669 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Sell | D | 0.00 | 96,021 | 0 | 0 | 96 K to 0 (-100.00 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 2.63 | 20,000 | 52,600 | 96,021 | 76 K to 96 K (+26.31 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 5.80 | 18,736 | 108,669 | 76,021 | 57.3 K to 76 K (+32.71 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | PAPASAN LARRY W | Director | Option Exercise | D | 12.66 | 8,538 | 108,091 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | PAPASAN LARRY W | Director | Option Exercise | D | 9.95 | 10,653 | 105,997 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | PAPASAN LARRY W | Director | Option Exercise | D | 11.64 | 8,840 | 102,898 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | PAPASAN LARRY W | Director | Option Exercise | D | 17.09 | 5,831 | 99,652 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | PAPASAN LARRY W | Director | Option Exercise | M | 2.63 | 20,000 | 52,600 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | PAPASAN LARRY W | Director | Option Exercise | M | 5.80 | 18,376 | 106,581 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | PAPASAN LARRY W | Director | Sell | D | 0.00 | 69,517 | 0 | 0 | 69.5 K to 0 (-100.00 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | PAPASAN LARRY W | Director | Buy | M | 2.63 | 20,000 | 52,600 | 69,517 | 49.5 K to 69.5 K (+40.39 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | PAPASAN LARRY W | Director | Buy | M | 5.80 | 18,736 | 108,669 | 49,517 | 30.8 K to 49.5 K (+60.87 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Option Exercise | D | 2.08 | 80,000 | 166,400 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Option Exercise | D | 13.45 | 40,000 | 538,000 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Option Exercise | D | 11.97 | 37,500 | 448,875 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Option Exercise | D | 8.54 | 30,000 | 256,200 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Option Exercise | D | 14.41 | 25,000 | 360,250 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Option Exercise | D | 12.59 | 27,000 | 339,930 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Option Exercise | D | 2.87 | 112,500 | 322,875 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Sell | D | 0.00 | 21,000 | 0 | 0 | 21 K to 0 (-100.00 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Sell | D | 0.00 | 89,151 | 0 | 0 | 89.2 K to 0 (-100.00 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Option Exercise | D | 11.97 | 75,000 | 897,750 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Option Exercise | D | 8.54 | 80,000 | 683,200 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Option Exercise | D | 12.59 | 80,000 | 1,007,200 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Option Exercise | D | 13.45 | 85,000 | 1,143,250 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Option Exercise | D | 13.88 | 205,703 | 2,855,158 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Option Exercise | D | 14.41 | 45,000 | 648,450 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Option Exercise | M | 2.08 | 170,000 | 353,600 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Option Exercise | M | 3.47 | 51,000 | 176,970 | 0 | |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | D | 0.00 | 5,550 | 0 | 0 | 5.6 K to 0 (-100.00 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | D | 0.00 | 1,392,923 | 0 | 0 | 1.4 M to 0 (-100.00 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Payment of Exercise | F | 9.07 | 77,623 | 704,336 | 1,392,923 | 1.5 M to 1.4 M (-5.28 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Buy | M | 2.08 | 170,000 | 353,600 | 1,470,546 | 1.3 M to 1.5 M (+13.07 %) |
Mar 05 2013 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Buy | M | 3.47 | 51,000 | 176,970 | 1,300,546 | 1.2 M to 1.3 M (+4.08 %) |
Jan 24 2013 | BMTI | BIOMIMETIC THERAPE ... | Pagano Russell P. | VP, Reg. & Clinical ... | Sell | S | 8.10 | 1,381 | 11,187 | 6,716 | 8.1 K to 6.7 K (-17.06 %) |
Jun 12 2012 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | A | 2.63 | 20,000 | 52,600 | 20,000 | |
Jun 12 2012 | BMTI | BIOMIMETIC THERAPE ... | PAPASAN LARRY W | Director | Option Exercise | A | 2.63 | 20,000 | 52,600 | 20,000 | |
Jun 12 2012 | BMTI | BIOMIMETIC THERAPE ... | MURPHY JAMES G | Director | Option Exercise | A | 2.63 | 20,000 | 52,600 | 20,000 | |
Jun 12 2012 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Option Exercise | A | 2.63 | 20,000 | 52,600 | 20,000 | |
Jun 12 2012 | BMTI | BIOMIMETIC THERAPE ... | FEDERICO CHARLES | Director | Option Exercise | A | 2.63 | 20,000 | 52,600 | 20,000 | |
Apr 16 2012 | BMTI | BIOMIMETIC THERAPE ... | Pagano Russell P. | VP, Reg. & Clinical ... | Sell | S | 2.36 | 3,438 | 8,128 | 5,996 | 9.4 K to 6 K (-36.44 %) |
Apr 04 2012 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Buy | P | 2.79 | 10,000 | 27,923 | 43,995 | 34 K to 44 K (+29.42 %) |
Mar 30 2012 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Buy | P | 2.40 | 20,000 | 48,000 | 1,239,391 | 1.2 M to 1.2 M (+1.64 %) |
Mar 30 2012 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Buy | P | 2.46 | 19,362 | 47,632 | 1,219,391 | 1.2 M to 1.2 M (+1.61 %) |
Mar 30 2012 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Buy | P | 2.38 | 30,638 | 72,891 | 1,200,029 | 1.2 M to 1.2 M (+2.62 %) |
Mar 29 2012 | BMTI | BIOMIMETIC THERAPE ... | PAPASAN LARRY W | Director | Buy | P | 2.34 | 2,400 | 5,606 | 30,781 | 28.4 K to 30.8 K (+8.46 %) |
Mar 29 2012 | BMTI | BIOMIMETIC THERAPE ... | PAPASAN LARRY W | Director | Buy | P | 2.32 | 3,000 | 6,951 | 28,381 | 25.4 K to 28.4 K (+11.82 %) |
Mar 29 2012 | BMTI | BIOMIMETIC THERAPE ... | PAPASAN LARRY W | Director | Buy | P | 2.32 | 3,000 | 6,954 | 25,381 | 22.4 K to 25.4 K (+13.40 %) |
Mar 29 2012 | BMTI | BIOMIMETIC THERAPE ... | PAPASAN LARRY W | Director | Buy | P | 2.32 | 2,000 | 4,636 | 22,381 | 20.4 K to 22.4 K (+9.81 %) |
Mar 28 2012 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Buy | P | 2.35 | 450 | 1,058 | 5,550 | 5.1 K to 5.6 K (+8.82 %) |
Mar 28 2012 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Buy | P | 2.35 | 2,700 | 6,345 | 1,169,391 | 1.2 M to 1.2 M (+0.23 %) |
Mar 28 2012 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Buy | P | 2.35 | 10,000 | 23,500 | 1,166,691 | 1.2 M to 1.2 M (+0.86 %) |
Mar 28 2012 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Sell | S | 2.35 | 8,000 | 18,822 | 11,056 | 19.1 K to 11.1 K (-41.98 %) |
Mar 28 2012 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Sell | S | 2.37 | 461 | 1,093 | 19,056 | 19.5 K to 19.1 K (-2.36 %) |
Mar 28 2012 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Sell | S | 2.38 | 5,000 | 11,910 | 19,517 | 24.5 K to 19.5 K (-20.39 %) |
Mar 28 2012 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Sell | S | 2.37 | 5,000 | 11,850 | 24,517 | 29.5 K to 24.5 K (-16.94 %) |
Mar 28 2012 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Sell | S | 2.36 | 2,000 | 4,720 | 29,517 | 31.5 K to 29.5 K (-6.35 %) |
Mar 28 2012 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Sell | S | 2.35 | 300 | 705 | 31,517 | 31.8 K to 31.5 K (-0.94 %) |
Mar 28 2012 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Sell | S | 2.35 | 400 | 940 | 31,817 | 32.2 K to 31.8 K (-1.24 %) |
Mar 28 2012 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Sell | S | 2.35 | 1,300 | 3,055 | 32,217 | 33.5 K to 32.2 K (-3.88 %) |
Mar 28 2012 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Sell | S | 2.36 | 5,000 | 11,800 | 33,517 | 38.5 K to 33.5 K (-12.98 %) |
Mar 28 2012 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Sell | S | 2.34 | 3,000 | 7,024 | 38,517 | 41.5 K to 38.5 K (-7.23 %) |
Mar 28 2012 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Sell | S | 2.35 | 6,000 | 14,100 | 41,517 | 47.5 K to 41.5 K (-12.63 %) |
Mar 28 2012 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Sell | S | 2.33 | 1,400 | 3,262 | 47,517 | 48.9 K to 47.5 K (-2.86 %) |
Mar 28 2012 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Sell | S | 2.34 | 3,300 | 7,722 | 48,917 | 52.2 K to 48.9 K (-6.32 %) |
Mar 28 2012 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Sell | S | 2.33 | 200 | 466 | 52,217 | 52.4 K to 52.2 K (-0.38 %) |
Mar 28 2012 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Sell | S | 2.32 | 1,100 | 2,552 | 52,417 | 53.5 K to 52.4 K (-2.06 %) |
Mar 28 2012 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Sell | S | 2.35 | 5,000 | 11,750 | 53,517 | 58.5 K to 53.5 K (-8.54 %) |
Mar 28 2012 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Sell | S | 2.34 | 5,000 | 11,700 | 58,517 | 63.5 K to 58.5 K (-7.87 %) |
Mar 28 2012 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Sell | S | 2.35 | 1,100 | 2,585 | 63,517 | 64.6 K to 63.5 K (-1.70 %) |
Mar 21 2012 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Buy | P | 2.20 | 17,670 | 38,874 | 78,723 | 61.1 K to 78.7 K (+28.94 %) |
Mar 21 2012 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Buy | P | 2.20 | 2,330 | 5,126 | 61,053 | 58.7 K to 61.1 K (+3.97 %) |
Mar 21 2012 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Buy | P | 2.19 | 5,000 | 10,949 | 11,762 | 6.8 K to 11.8 K (+73.94 %) |
Mar 21 2012 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Buy | P | 2.18 | 5,000 | 10,921 | 14,894 | 9.9 K to 14.9 K (+50.54 %) |
Mar 21 2012 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Buy | P | 2.20 | 5,000 | 10,984 | 33,995 | 29 K to 34 K (+17.24 %) |
Mar 21 2012 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | J | 0.00 | 42,269 | 0 | 0 | 42.3 K to 0 (-100.00 %) |
Mar 21 2012 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Gift | G | 0.00 | 100,000 | 0 | 42,269 | 142.3 K to 42.3 K (-70.29 %) |
Mar 21 2012 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Buy | J | 0.00 | 42,269 | 0 | 1,156,691 | 1.1 M to 1.2 M (+3.79 %) |
Mar 21 2012 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Gift | G | 0.00 | 100,000 | 0 | 1,114,422 | 1 M to 1.1 M (+9.86 %) |
Mar 02 2012 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Option Exercise | A | 2.08 | 170,000 | 353,600 | 170,000 | |
Mar 02 2012 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Option Exercise | A | 2.08 | 80,000 | 166,400 | 80,000 | |
Mar 02 2012 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Option Exercise | A | 2.08 | 80,000 | 166,400 | 80,000 | |
Mar 02 2012 | BMTI | BIOMIMETIC THERAPE ... | Pagano Russell P. | VP, Reg. & Clinical ... | Option Exercise | A | 2.08 | 70,000 | 145,600 | 70,000 | |
Feb 13 2012 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Gift | G | 0.00 | 112,072 | 0 | 142,269 | 254.3 K to 142.3 K (-44.06 %) |
Feb 13 2012 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Gift | G | 0.00 | 112,072 | 0 | 1,014,422 | 902.4 K to 1 M (+12.42 %) |
Feb 13 2012 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Gift | G | 0.00 | 16,000 | 0 | 28,000 | 12 K to 28 K (+133.33 %) |
Feb 13 2012 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Gift | G | 0.00 | 16,000 | 0 | 58,723 | 74.7 K to 58.7 K (-21.41 %) |
Oct 14 2011 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Sell | S | 3.06 | 3,000 | 9,167 | 57,144 | 60.1 K to 57.1 K (-4.99 %) |
Oct 14 2011 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Sell | S | 2.98 | 3,000 | 8,942 | 60,144 | 63.1 K to 60.1 K (-4.75 %) |
Oct 14 2011 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Sell | S | 2.99 | 3,000 | 8,971 | 63,144 | 66.1 K to 63.1 K (-4.54 %) |
Oct 11 2011 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Sell | S | 3.01 | 3,000 | 9,016 | 66,144 | 69.1 K to 66.1 K (-4.34 %) |